Lübeck-based German publicly-listed manufacturer of anesthesia, ventilation, patient monitoring, and emergency care equipment — one of the largest installed bases in European hospital capital equipment.
Drägerwerk AG & Co. KGaA — commonly known simply as Dräger — is one of Germany's most established medical and safety technology companies, founded in 1889 in Lübeck. The company operates in two reporting segments: Medical (anesthesia, ventilation, patient monitoring, neonatal care, hospital infrastructure) and Safety (gas detection, respiratory protection, alcohol and drug detection). For the purposes of this directory, the focus is the Medical segment.
Dräger is listed on the Frankfurt Stock Exchange (ticker: DRW3) and reports annual group revenues of approximately €3.5 billion, with the Medical segment accounting for roughly 55-60 percent of that. The Dräger family retains family control through the general partner structure of the KGaA — a German legal form designed to preserve founding-family governance in publicly-traded companies.
Dräger's medical portfolio is concentrated in four high-acuity hospital settings — operating room, intensive care, neonatal/pediatric, and emergency. The product families are:
Flagship products in the Atlan and Perseus series serve hospital ORs across Europe. Anesthesia workstations are deeply embedded capital equipment — installations typically last 10-15 years — making Dräger one of the most strategically important suppliers in any European hospital's procurement budget.
The Evita V and Babylog VN800 ventilator families serve adult ICU and neonatal applications respectively. Dräger gained significant global market share during the 2020-2022 pandemic when its production scaled rapidly. The installed base across European ICUs is one of the largest of any single manufacturer.
The Vista 120 and Infinity Acute Care patient monitoring systems compete with Philips IntelliVue and Mindray. Less dominant than Dräger's anesthesia or ventilation positions but still strategically important for hospital tender packages.
The Babyleo open warmer and Caleo incubator are category leaders in European NICU equipment. Specialty distribution — limited number of decision-makers, deep clinical relationships matter more than tender capacity.
Dräger sells primarily direct in major European markets — the company maintains country-level subsidiaries in Germany, France, UK, Italy, Spain, Netherlands, Belgium, Austria, Switzerland, Poland, and the Nordic markets. In smaller European markets and outside Europe, the company appoints exclusive distributors with capital-equipment service capability and clinical applications expertise.
For a non-Dräger manufacturer evaluating the European hospital capital equipment landscape, Dräger functions more as a competitor than a distribution partner — they do not generally distribute third-party capital equipment that competes with their own portfolio. However, they have selectively partnered with manufacturers of complementary products (some IT/EMR vendors, certain consumable lines for their installed devices) where there is clear strategic logic.
Dräger is the leading domestic supplier of anesthesia workstations and adult ICU ventilators in Germany, with installed positions in essentially every university hospital, most regional general hospitals, and many specialty centers. The company is pre-listed on framework agreements with the major Einkaufsgemeinschaften (GDEKK, Sana Einkauf, P.E.G., AGKAMED) for capital equipment categories and serves the Bundeswehr (German military medical services) as a long-standing supplier.
Procurement of Dräger equipment in Germany typically involves the hospital's Technical Department alongside Clinical Procurement — the technical complexity, service requirements, and integration with hospital information systems mean purchasing decisions are not made by procurement alone.
Dräger operates Medical-segment subsidiaries with capital equipment sales and service organizations in all major European markets. The combined European installed base represents one of the most strategically embedded positions any single MedTech manufacturer holds — particularly in France (CHU university hospitals), Italy (regional ICU networks), UK (NHS Trusts), and the Nordic markets.
As a major German publicly-listed manufacturer-distributor, Dräger maintains its own EU MDR compliance infrastructure, ISO 13485-certified quality management, FDA 510(k) clearances for its US-marketed products, and a Medizinprodukteberater function compliant with German MPDG requirements. Service organization in each major country meets local regulatory requirements for installed device maintenance and recall management.
Dräger's role for non-Dräger manufacturers is rarely as a primary distributor — but understanding their commercial structure is essential because they shape the European capital equipment competitive landscape. Key considerations:
Fractio supports European medical device launches across exactly this terrain — capital equipment tenders, installed-base displacement strategies, distributor partner selection.
Talk to Fractio → More German distributors